Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
Daniel D TruongThe Parkinson’s and Movement Disorder Institute, Fountain Valley, CA, USAAbstract: Levodopa has been the gold standard therapy for the motor symptoms of Parkinson’s disease for more than three decades. Although it remains the most effective treatment, its long-term...
Guardado en:
Autor principal: | Daniel D Truong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9fcd20210b9b449ba39586dd455c022e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: José-Francisco Rocha, et al.
Publicado: (2021) -
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
por: Werner Poewe, et al.
Publicado: (2010) -
A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
por: A Ahmadi Ahangar, et al.
Publicado: (2002) -
Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
por: Patel AB, et al.
Publicado: (2018) -
COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia
por: Kaneko H, et al.
Publicado: (2018)